"Consumers and health care professionals will soon find updated labeling for extended-release and long-acting opioid pain relievers to help ensure their safe and appropriate use.
In addition to requiring new labeling on these prescript"...
Patients should be advised of the following information:
- NUBAIN (nalbuphine hydrochloride) is associated with sedation and may impair mental and physical abilities required for the performance of potentially dangerous tasks such as driving a car or operating machinery.
- NUBAIN (nalbuphine hydrochloride) is to be used as prescribed by a physician. Dose or frequency should not be increased without first consulting with a physician since NUBAIN (nalbuphine hydrochloride) may cause psychological or physical dependence.
- The use of NUBAIN (nalbuphine hydrochloride) with other opioids can cause signs and symptoms of withdrawal.
- Abrupt discontinuation of NUBAIN (nalbuphine hydrochloride) after prolonged usage may cause signs and symptoms of withdrawal.
Last reviewed on RxList: 1/4/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Nubain Information
Report Problems to the Food and Drug Administration
Chronic Pain/Back Pain
Find tips and advances in treatment.